First Time Loading...

Aerie Pharmaceuticals Inc
NASDAQ:AERI

Watchlist Manager
Aerie Pharmaceuticals Inc Logo
Aerie Pharmaceuticals Inc
NASDAQ:AERI
Watchlist
Price: 15.25 USD 0.07% Market Closed
Updated: May 4, 2024

Aerie Pharmaceuticals Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aerie Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Aerie Pharmaceuticals Inc
NASDAQ:AERI
Cash from Investing Activities
-$18.3m
CAGR 3-Years
44%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
$878m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$21.7B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-96%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.2B
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
-13%

See Also

What is Aerie Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
-18.3m USD

Based on the financial report for Sep 30, 2022, Aerie Pharmaceuticals Inc's Cash from Investing Activities amounts to -18.3m USD.

What is Aerie Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
20%

Over the last year, the Cash from Investing Activities growth was 14%. The average annual Cash from Investing Activities growth rates for Aerie Pharmaceuticals Inc have been 44% over the past three years , 20% over the past five years .